Advertisement

Pancreas

  • Kenji Notohara
Chapter

Abstract

The histological findings of type 1 autoimmune (IgG4-related) pancreatitis (AIP), also called lymphoplasmacytic sclerosing pancreatitis, encompass diverse lesions in which marked lymphoplasmacytic infiltration and fibrosis envelop the pancreatic ducts, lobules, peripancreatic adipose tissue, and blood vessels. The concept of this disease was proposed based on histological analyses that revealed a pathological picture characterized by storiform fibrosis and obliterative phlebitis. Accordingly, the histological findings are essential to making the diagnosis which is more important, even, than the finding of IgG4-positive plasmacytic infiltration, which is nonspecific in the absence of the appropriate background morphology.

In contrast to type 1 AIP, type 2 AIP presents with inflammation centered on exocrine tissue extending from the pancreatic ducts to within the lobules. Neutrophil infiltration of the pancreatic duct lumen and/or epithelium (granulocytic epithelial lesion; GEL) is characteristic of type 2 AIP, and when GEL is noted within the interlobular pancreatic ducts, a definitive diagnosis can be made.

Keywords

Pancreatic Duct Lymphoplasmacytic Infiltration Fibrotic Focus Obliterative Phlebitis Pancreatic Duct Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–95.PubMedCrossRefGoogle Scholar
  2. 2.
    Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997;41:263–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration. Clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–27.PubMedCrossRefGoogle Scholar
  4. 4.
    Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Chari S, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549–54.PubMedCrossRefGoogle Scholar
  10. 10.
    Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Notohara K, Arimoto M, Wani Y, et al. Autoimmune pancreatitis: pancreatic manifestation of IgG4-related disease. Pathol Case Rev. 2010;15:219–24.CrossRefGoogle Scholar
  13. 13.
    Notohara K, Wani Y, Fujisawa M. Pathologic findings of autoimmune pancreatitis and IgG4-related disease. Curr Immunol Rev. 2011;7:212–20.CrossRefGoogle Scholar
  14. 14.
    Dhall D, Suriawinata AA, Tang LH, et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41:643–52.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Department of Anatomic PathologyKurashiki Central HospitalKurashikiJapan

Personalised recommendations